Advertisement
Screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Material Contracts, 2024

IOVANCE BIOTHERAPEUTICS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2024-08-08: Form 10-Q; Exhibit 10.2; Description Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended..
  • 2024-08-08: Form 10-Q; Exhibit 10.1; Description Iovance Biotherapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended..
  • 2024-05-09: Form 10-Q; Exhibit 10.2; Description Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended..
  • 2024-05-09: Form 10-Q; Exhibit 10.1; Description Iovance Biotherapeutics, Inc. Amended and Restated 2021 Inducement Plan..
FiledFormExhibitDescription
2024-08-0810-Q10.2Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended.
2024-08-0810-Q10.1Iovance Biotherapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended.
2024-05-0910-Q10.2Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended.
2024-05-0910-Q10.1Iovance Biotherapeutics, Inc. Amended and Restated 2021 Inducement Plan.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B